Article Details
Retrieved on: 2025-04-09 14:22:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article explores the role of machine learning in streamlining drug discovery and development for rare diseases, addressing high costs and inefficiencies. It highlights industry shifts involving companies like Pfizer and AstraZeneca, driven by economic and strategic challenges.
Article found on: www.appliedclinicaltrialsonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here